Article
Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.
PLoS neglected tropical diseases - 1 Jan 2012
Fan Yi-Chin, Chen Jo-Mei, Chiu Hsien-Chung, Chen Yi-Ying, Lin Jen-Wei, Shih Chen-Chang, Chen Chih-Ming, Chang Chao-Chin, Chang Gwong-Jen J, Chiou Shyan-Song
Abstract excerpt
BACKGROUND: Genotype I (GI) Japanese encephalitis virus (JEV) that replaced GIII virus has become the dominant circulating virus in Asia. Currently, all registered live and inactivated JEV vaccines are derived from genotype III viruses. In Taiwan, the compulsory JEV vaccination policy recommends...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
